EXEL
NASDAQ · Biotechnology
Exelixis Inc
$48.16
+1.95 (+4.22%)
Performance
1D
—
1W
—
1M
—
3M
+9.58%
6M
+16.30%
1Y
+33.15%
YTD
+10.51%
Open$46.59
Previous Close$46.21
Day High$48.17
Day Low$46.46
52W High$49.62
52W Low$33.76
Volume—
Avg Volume3.10M
Market Cap11.96B
P/E Ratio15.29
EPS$2.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$43.59
Above
SMA 200
$41.49
Above
RSI (14)
62
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
27 analysts
Price Target
+141.1% upside
Current
$48.16
$48.16
Target
$116.10
$116.10
$78.53
$116.10 avg
$123.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.04B | 1.81B | 2.68B |
| Net Income | 689.60M | 549.58M | -77,688,294 |
| Profit Margin | 33.7% | 32.0% | -2.9% |
| EBITDA | 794.02M | 667.95M | -84,355,918 |
| Free Cash Flow | — | — | -70,301,392 |
| Rev Growth | +12.9% | +12.9% | +9.9% |
| Debt/Equity | — | — | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |